Combination therapy of animal tumors with L-asparaginase and antagonists of glutamine or glutamic acid.
D000596:Amino Acids / Q000008:administration & dosage / Q000494:pharmacology; D000613:Aminobutyrates / Q000008:administration & dosage / Q000494:pharmacology; D000818:Animals; D001215:Asparaginase / Q000008:administration & dosage*; D001377:Azaserine / Q000008:administration & dosage; D001835:Body Weight; D002279:Carcinoma 256, Walker / Q000188:drug therapy; D002286:Carcinoma, Ehrlich Tumor / Q000188:drug therapy*; D004357:Drug Synergism; D018691:Excitatory Amino Acid Antagonists; D005260:Female; D005973:Glutamine / Q000037:antagonists & inhibitors; D006601:Hexoses / Q000008:administration & dosage; D008297:Male; D008545:Melanoma / Q000188:drug therapy; D051379:Mice; D009374:Neoplasms, Experimental / Q000188:drug therapy; D051381:Rats
D000596:Amino Acids; D000613:Aminobutyrates; D018691:Excitatory Amino Acid Antagonists; D006601:Hexoses; D005973:Glutamine; D001377:Azaserine; D001215:Asparaginase